Predictive biomarkers for colorectal cancer: a state-of-the-art systematic review

References

• Ahmed, M., 2020. Colon cancer: a clinician’s perspective in 2019. Gastroenterology research, 13 (1), 1–10.
   PubMed Web of Science ®Google Scholar
• Al-Joufi, F.A., et al., 2022. Molecular pathogenesis of colorectal cancer with an emphasis on recent advances in biomarkers, as well as nanotechnology-based diagnostic and therapeutic approaches. Nanomaterials, 12 (1), 169.
   Web of Science ®Google Scholar
• Amato, M., et al., 2022. Microsatellite instability: from the implementation of the detection to a prognostic and predictive role in cancers. International journal of molecular sciences, 23 (15), 8726.
   PubMed Web of Science ®Google Scholar
• Anderson, O.S., Sant, K.E., and Dolinoy, D.C., 2012. Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. Journal of nutritional biochemistry, 23 (8), 853–859.
   PubMed Web of Science ®Google Scholar
• Arasaradnam, R.P., et al., 2014. Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis. PloS one, 9 (9), e108750.
   PubMed Web of Science ®Google Scholar
• Arnold, M., et al., 2017. Global patterns and trends in colorectal cancer incidence and mortality. Gut, 66 (4), 683–691.
   PubMed Web of Science ®Google Scholar
• Avolio, M., and Trusolino, L., 2021. Rational treatment of metastatic colorectal cancer: a reverse tale of men, mice, and culture dishes preclinical models for colorectal cancer. Cancer discovery, 11 (7), 1644–1660.
   PubMed Web of Science ®Google Scholar
• Bagheri, H., et al., 2020. TFPI2 and NDRG4 gene promoter methylation analysis in peripheral blood mononuclear cells are novel epigenetic noninvasive biomarkers for colorectal cancer diagnosis. Journal of gene medicine, 22 (8), e3189.
   PubMed Web of Science ®Google Scholar
• Banday, M.Z., Sameer, A.S., and Nissar, S., 2021. Colorectal cancer and genetic polymorphism in key regulatory low penetrance genes. Genetic polymorphism and cancer susceptibility, 20, 119–164.
   Google Scholar
• Banks, M., et al., 2019. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut, 68 (9), 1545–1575.
   PubMed Web of Science ®Google Scholar
• Baraniskin, A., et al., 2013. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma. International journal of cancer, 132 (2), E48–E57.
   PubMed Web of Science ®Google Scholar
• Barry, E.S., Merkebu, J., and Varpio, L., 2022. State-of-the-art literature review methodology: a six-step approach for knowledge synthesis. Perspectives on medical education, 11 (5), 281–288.
   PubMed Web of Science ®Google Scholar
• Baxter, N.N., et al., 2022. Adjuvant therapy for stage II colon cancer: ASCO guideline update. Journal of clinical oncology: official journal of the American society of clinical oncology, 40 (8), 892–910.
   PubMed Web of Science ®Google Scholar
• Bergstrom, D.J., et al., 2020. Consensus guidelines on the diagnosis of multiple myeloma and related disorders: recommendations of the myeloma Canada research network consensus guideline consortium. Clinical lymphoma, myeloma & leukemia, 20 (7), e352–e367.
   PubMed Web of Science ®Google Scholar
• Blann, A., and Ahmed, N., 2023. Blood science: principles and pathology. Hoboken, NJ: John Wiley & Sons.
   Google Scholar
• Boussios, S., et al., 2019. The developing story of predictive biomarkers in colorectal cancer. Journal of personalized medicine, 9 (1), 12.
   PubMed Web of Science ®Google Scholar
• Bratulic, S., Gatto, F., and Nielsen, J., 2021. The translational status of cancer liquid biopsies. Regenerative engineering and translational medicine, 7 (3), 312–352.
   Web of Science ®Google Scholar
• Bresalier, R.S., et al., 2020. Biomarkers for early detection of colorectal cancer: the early detection research network, a framework for clinical translation. Cancer epidemiology, biomarkers & prevention: a publication of the American association for cancer research, cosponsored by the American society of preventive oncology, 29 (12), 2431–2440.
   PubMed Web of Science ®Google Scholar
• Brunet Vega, A., et al., 2013. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers. Oncology reports, 30 (1), 320–326.
   PubMed Web of Science ®Google Scholar
• Burnett-Hartman, A.N., et al., 2021. An update on the epidemiology, molecular characterization, diagnosis, and screening strategies for early-onset colorectal cancer. Gastroenterology, 160 (4), 1041–1049.
   PubMed Web of Science ®Google Scholar
• Cai, J., et al., 2019. Long noncoding RNAs serve as potential diagnostic biomarkers for colorectal cancer. Journal of cancer, 10 (3), 611–619.
   PubMed Web of Science ®Google Scholar
• Carethers, J.M., and Doubeni, C.A., 2020. Causes of socioeconomic disparities in colorectal cancer and intervention framework and strategies. Gastroenterology, 158 (2), 354–367.
   PubMed Web of Science ®Google Scholar
• Christou, N., et al., 2019. Circulating tumour cells, circulating tumour DNA and circulating tumour miRNA in blood assays in the different steps of colorectal cancer management, a review of the evidence. BioMed research international, 2019, 5953036.
   PubMedGoogle Scholar
• Chubak, J., et al., 2016. Time to colonoscopy after positive fecal blood test in four U.S. health care systems. Cancer epidemiology, biomarkers & prevention: a publication of the American association for cancer research, cosponsored by the American society of preventive oncology, 25 (2), 344–350.
   PubMed Web of Science ®Google Scholar
• Colditz, G.A., Hoaglin, D.C., and Berkey, C.S., 1997. Cancer incidence and mortality: the priority of screening frequency and population coverage. Milbank quarterly, 75 (2), 147–173.
   PubMed Web of Science ®Google Scholar
• Conti, L., Del Cornò, M., and Gessani, S., 2020. Revisiting the impact of lifestyle on colorectal cancer risk in a gender perspective. Critical reviews in oncology/hematology, 145, 102834.
   PubMed Web of Science ®Google Scholar
• Crosby, D., et al., 2022. Early detection of cancer. Science (New York, N.Y.), 375 (6586), eaay9040.
   PubMed Web of Science ®Google Scholar
• Crotta, S., et al., 2012. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test. Clinical gastroenterology and hepatology: the official clinical practice journal of the American gastroenterological association, 10 (6), 633–638.
   PubMed Web of Science ®Google Scholar
• Das, V., Kalita, J., and Pal, M., 2017. Predictive and prognostic biomarkers in colorectal cancer: a systematic review of recent advances and challenges. Biomedicine & pharmacotherapy = biomedecine & pharmacotherapie, 87, 8–19.
   PubMed Web of Science ®Google Scholar
• Dawson, H., et al., 2019. A review of current challenges in colorectal cancer reporting. Archives of pathology & laboratory medicine, 143 (7), 869–882.
   PubMed Web of Science ®Google Scholar
• DeVos, T., et al., 2009. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clinical chemistry, 55 (7), 1337–1346.
   PubMed Web of Science ®Google Scholar
• Dillon, R., et al., 2018. Analytical validation of a novel multiplex test for detection of advanced adenoma and colorectal cancer in symptomatic patients. Journal of pharmaceutical and biomedical analysis, 154, 85–94.
   PubMed Web of Science ®Google Scholar
• Di Zazzo, E., Intrieri, M., and Davinelli, S., 2023. Liquid biopsy and cancer: an ongoing story. Journal of clinical medicine, 12 (7), 2690.
   PubMed Web of Science ®Google Scholar
• Dobre, M., et al., 2021. Crosstalk between DNA methylation and gene mutations in colorectal cancer. Frontiers in oncology, 11, 697409.
   PubMed Web of Science ®Google Scholar
• Dong, L., and Ren, H., 2018. Blood-based DNA methylation biomarkers for early detection of colorectal cancer. Journal of proteomics & bioinformatics, 11 (6), 120–126.
   PubMedGoogle Scholar
• Douaiher, J., et al., 2017. Colorectal cancer—global burden, trends, and geographical variations. Journal of surgical oncology, 115 (5), 619–630.
   PubMed Web of Science ®Google Scholar
• Draht, M.X.G., et al., 2018. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review. Clinical epigenetics, 10, 35.
   PubMed Web of Science ®Google Scholar
• Ebner, D.W., and Kisiel, J.B., 2020. Stool-based tests for colorectal cancer screening: performance benchmarks lead to high expected efficacy. Current gastroenterology reports, 22 (7), 32.
   PubMedGoogle Scholar
• Ewing, I., et al., 2014. The molecular genetics of colorectal cancer. Frontline gastroenterology, 5 (1), 26–30.
   PubMedGoogle Scholar
• Fadaka, A.O., Pretorius, A., and Klein, A., 2019. Biomarkers for stratification in colorectal cancer: microRNAs. Cancer control: journal of the moffitt cancer center, 26 (1), 1073274819862784.
   Web of Science ®Google Scholar
• Faria, S.C., et al., 2019. Tumor markers: myths and facts unfolded. Abdominal radiology (New York), 44 (4), 1575–1600.
   PubMed Web of Science ®Google Scholar
• Fatemi, N., et al., 2022. DNA methylation biomarkers in colorectal cancer: clinical applications for precision medicine. International journal of cancer, 151 (12), 2068–2081.
   PubMed Web of Science ®Google Scholar
• Ferlay, J., et al., 2018. ‘Global cancer observatory: cancer today’, Lyon, France. International agency for research on cancer, 3(20), 2019.
   Google Scholar
• Gallardo-Gómez, M., et al., 2018. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples. Clinical epigenetics, 10 (1), 53.
   PubMedGoogle Scholar
• Gandomani, H.S., et al., 2017. Colorectal cancer in the world: incidence, mortality and risk factors. Biomedical research and therapy, 4 (10), 1656–1675.
   Google Scholar
• Geiger, T.M., and Ricciardi, R., 2009. Screening options and recommendations for colorectal cancer. Clinics in colon and rectal surgery, 22 (4), 209–217.
   PubMedGoogle Scholar
• Gezer, U., et al., 2015. Histone methylation marks on circulating nucleosomes as novel blood-based biomarker in colorectal cancer. International journal of molecular sciences, 16 (12), 29654–29662.
   PubMed Web of Science ®Google Scholar
• Ghareib, A.F., et al., 2020. Assessment of serum MicroRNA-21 gene expression for diagnosis and prognosis of colorectal cancer. Journal of gastrointestinal cancer, 51 (3), 818–823.
   PubMed Web of Science ®Google Scholar
• Grimm, I.S., and McGill, S.K., 2019. Look, but don’t touch: what not to do in managing large colorectal polyps. Gastrointestinal endoscopy, 89 (3), 479–481.
   PubMed Web of Science ®Google Scholar
• Gu, Y., et al., 2023. Non-coding RNAs and colitis-associated cancer: mechanisms and clinical applications. Clinical and translational medicine, 13 (5), e1253.
   PubMed Web of Science ®Google Scholar
• Hammoudi, A., et al., 2013. Proteomic profiling of a mouse model of acute intestinal Apc deletion leads to identification of potential novel biomarkers of human colorectal cancer (CRC). Biochemical and biophysical research communications, 440 (3), 364–370.
   PubMed Web of Science ®Google Scholar
• Hariharan, R., and Jenkins, M., 2020. Utility of the methylated SEPT9 test for the early detection of colorectal cancer: a systematic review and meta-analysis of diagnostic test accuracy. BMJ open gastroenterology, 7 (1), e000355.
   PubMed Web of Science ®Google Scholar
• He, J., et al., 2021. Biomarkers (mRNAs and non-coding RNAs) for the diagnosis and prognosis of colorectal cancer–from the body fluid to tissue level. Frontiers in oncology, 11, 632834.
   PubMed Web of Science ®Google Scholar
• Heidrich, I., et al., 2021. Clinical applications of circulating tumor cells and circulating tumor DNA as a liquid biopsy marker in colorectal cancer. Cancers, 13 (18), 4500.
   PubMed Web of Science ®Google Scholar
• Hendricks, A., et al., 2021. Longitudinal analysis of circulating tumor cells in colorectal cancer patients by a cytological and molecular approach: feasibility and clinical application. Frontiers in oncology, 11, 646885.
   PubMed Web of Science ®Google Scholar
• Horisberger, K., Mann, C., and Lang, H., 2023. Current surgical concepts in lynch syndrome and familial adenomatous polyposis. Visceral medicine, 39 (1), 1–8.
   PubMed Web of Science ®Google Scholar
• Huang, Z., and Yang, M., 2022. Molecular network of colorectal cancer and current therapeutic options. Frontiers in oncology, 12, 852927.
   Web of Science ®Google Scholar
• Imaoka, H., et al., 2016. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer. Annals of oncology, 27 (10), 1879–1886.
   PubMed Web of Science ®Google Scholar
• Inoue, A., et al., 2019. Current and future horizons of patient-derived xenograft models in colorectal cancer translational research. Cancers, 11 (9), 1321.
   PubMed Web of Science ®Google Scholar
• Ishibe, A., et al., 2018. Detection of gas components as a novel diagnostic method for colorectal cancer. Annals of gastroenterological surgery, 2 (2), 147–153.
   PubMed Web of Science ®Google Scholar
• Julich-Haertel, H., et al., 2017. Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma. Journal of hepatology, 67 (2), 282–292.
   PubMed Web of Science ®Google Scholar
• Jung, G., et al., 2020. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nature reviews gastroenterology & hepatology, 17 (2), 111–130.
   PubMed Web of Science ®Google Scholar
• Kamel, F., et al., 2022. Colorectal cancer diagnosis: the obstacles we face in determining a non-invasive test and current advances in biomarker detection. Cancers, 14 (8), 1889.
   PubMed Web of Science ®Google Scholar
• Keum, N., and Giovannucci, E., 2019. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nature reviews gastroenterology & hepatology, 16 (12), 713–732.
   PubMed Web of Science ®Google Scholar
• Khan, A.A., et al., 2021. An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression. Cancer and metastasis reviews, 40 (1), 245–272.
   PubMed Web of Science ®Google Scholar
• Kim, N.H., et al., 2017. Serum CEA and CA 19-9 levels are associated with the presence and severity of colorectal neoplasia. Yonsei medical journal, 58 (5), 918–924.
   PubMed Web of Science ®Google Scholar
• Knowlton, C.A., et al., 2022. Colon cancer. Encyclopedia of radiation oncology, 77–77.
   Google Scholar
• Knudsen, A.B., et al., 2016. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US preventive services task force. Jama-jama, 315 (23), 2595–2609.
   PubMed Web of Science ®Google Scholar
• Koncina, E., et al., 2020. Prognostic and predictive molecular biomarkers for colorectal cancer: updates and challenges. Cancers, 12 (2), 319.
   PubMed Web of Science ®Google Scholar
• Kontomanolis, E.N., et al., 2020. Role of oncogenes and tumor-suppressor genes in carcinogenesis: a review. Anticancer research, 40 (11), 6009–6015.
   PubMed Web of Science ®Google Scholar
• Krawczyk, P., et al., 2017. Evaluation of miR-506 and miR-4316 expression in early and non-invasive diagnosis of colorectal cancer. International journal of colorectal disease, 32 (7), 1057–1060.
   PubMed Web of Science ®Google Scholar
• Lakkis, N.A., El-Kibbi, O., and Osman, M.H., 2021. Colorectal cancer in Lebanon: incidence, temporal trends, and comparison to regional and Western countries. Cancer control, 28, 1073274821996869.
   Web of Science ®Google Scholar
• Laskaratos, F.-M., et al., 2020. Clinicopathological correlations of mesenteric fibrosis and evaluation of a novel biomarker for fibrosis detection in small bowel neuroendocrine neoplasms. Endocrine, 67 (3), 718–726.
   PubMed Web of Science ®Google Scholar
• Lin, J.S., et al., 2016. Screening for colorectal cancer: a systematic review for the U.S. preventive services task force. Evidence synthesis, 135 (135), 239. http://www.ncbi.nlm.nih.gov/pubmed/27441328
   Google Scholar
• Liskova, A., et al., 2020. Liquid biopsy is instrumental for 3PM dimensional solutions in cancer management. Journal of clinical medicine, 9 (9), 2749.
   PubMed Web of Science ®Google Scholar
• Liu, J., et al., 2022. Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer. BMC cancer, 22 (1), 1038.
   PubMed Web of Science ®Google Scholar
• López-Campos, F., et al., 2020. Watch and wait approach in rectal cancer: current controversies and future directions. World journal of gastroenterology, 26 (29), 4218–4239.
   PubMed Web of Science ®Google Scholar
• Maminezhad, H., et al., 2020. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer. Life sciences, 258, 118226.
   PubMed Web of Science ®Google Scholar
• Manjunath, K.N., Siddalingaswamy, P.C., and Prabhu, G.K., 2019. Domain-based analysis of colon polyp in CT colonography using image-processing techniques. Asian pacific journal of cancer prevention: APJCP, 20 (2), 629.
   PubMedGoogle Scholar
• Mao, R., et al., 2021. Genetic testing for inherited colorectal cancer and polyposis, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genetics in medicine, 23 (10), 1807–1817.
   PubMed Web of Science ®Google Scholar
• Marín-Vicente, C., et al., 2020. Identification and validation of stage-associated serum biomarkers in colorectal cancer using MS-based procedures. PROTEOMICS – clinical applications, 14 (1), 1900052.
   PubMed Web of Science ®Google Scholar
• McCarthy, A.M., et al., 2016. Follow-up of abnormal breast and colorectal cancer screening by race/ethnicity. American journal of preventive medicine, 51 (4), 507–512.
   PubMed Web of Science ®Google Scholar
• Meester, R.G.S., et al., 2015. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer, 121 (13), 2281–2285.
   PubMed Web of Science ®Google Scholar
• Migheli, F., and Migliore, L., 2012. Epigenetics of colorectal cancer. Clinical genetics, 81 (4), 312–318.
   PubMed Web of Science ®Google Scholar
• Miguel Pérez, D., et al., 2020. Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients. Scientific reports, 10 (1), 3974.
   PubMed Web of Science ®Google Scholar
• Miskovicova, M., et al., 2021. Novel spectroscopic biomarkers are applicable in non-invasive early detection and staging classification of colorectal cancer. Neoplasma, 67 (06), 1349–1358.
   Google Scholar
• Mohammadi, D., et al., 2022. Evaluation of plasma circ_0006282 as a novel diagnostic biomarker in colorectal cancer. Journal of clinical laboratory analysis, 36 (1), e24147.
   PubMed Web of Science ®Google Scholar
• Moralejo, D., Ogunremi, T., and Dunn, K., 2017. Scientific writing: Critical Appraisal Toolkit (CAT) for assessing multiple types of evidence. Canada communicable disease report, 43 (9), 176–181.
   PubMedGoogle Scholar
• Moyano, A., et al., 2021. Magnetic lateral flow immunoassay for small extracellular vesicles quantification: application to colorectal cancer biomarker detection. Sensors, 21 (11), 3756.
   PubMed Web of Science ®Google Scholar
• Mulliri, A., et al., 2023. Social inequalities in health: how do they influence the natural history of colorectal cancer?’. Journal of visceral surgery, 160 (3), 203–213.
   PubMed Web of Science ®Google Scholar
• Nagai, Y., et al., 2017. LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer. Oncotarget, 8 (7), 11906–11916.
   PubMedGoogle Scholar
• Nardone, O.M., et al., 2023. Inflammation-driven colorectal cancer associated with colitis: from pathogenesis to changing therapy. Cancers, 15 (8), 2389.
   PubMed Web of Science ®Google Scholar
• NCA. (n.d.). NCA - Screening for colorectal cancer - blood-based biomarker tests (CAG-00454N) - Decision Memo. Available from: https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&NCAId=299 (Accessed 23 June 2023).
   Google Scholar
• Nguyen, H.T., and Duong, H., 2018. The molecular characteristics of colorectal cancer: implications for diagnosis and therapy. Oncology letters, 16 (1), 9–18.
   PubMed Web of Science ®Google Scholar
• Nichita, C., et al., 2014. A novel gene expression signature in peripheral blood mononuclear cells for early detection of colorectal cancer. Alimentary pharmacology & therapeutics, 39 (5), 507–517.
   PubMed Web of Science ®Google Scholar
• Niedermaier, T., et al., 2017. Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling. European journal of epidemiology, 32 (6), 481–493.
   PubMed Web of Science ®Google Scholar
• Novikov, N.M., et al., 2021. Mutational drivers of cancer cell migration and invasion. British journal of cancer, 124 (1), 102–114.
   PubMed Web of Science ®Google Scholar
• Ogunwobi, O.O., Mahmood, F., and Akingboye, A., 2020. Biomarkers in colorectal cancer: current research and future prospects. International journal of molecular sciences, 21 (15), 5311.
   PubMed Web of Science ®Google Scholar
• Oh, H.J., et al., 2019. p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy. British journal of cancer, 120 (8), 797–805.
   PubMed Web of Science ®Google Scholar
• Okugawa, Y., et al., 2016. Elevated serum concentration of monocyte chemotactic protein 4 (MCP-4) as a novel non-invasive prognostic and predictive biomarker for detection of metastasis in colorectal cancer. Journal of surgical oncology, 114 (4), 483–489.
   PubMed Web of Science ®Google Scholar
• Ostendorff, H.P., et al., 2013. Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer. Journal of immunological methods, 400, 58–69.
   PubMed Web of Science ®Google Scholar
• Page, M.J., et al., 2021. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ (clinical research ed.), 372, n160.
   PubMed Web of Science ®Google Scholar
• Page, M.J., et al., 2021. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLOS medicine, 18 (3), e1003583.
   PubMed Web of Science ®Google Scholar
• Palanca-Ballester, C., et al., 2021. Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies. Cancers, 13 (12), 3016.
   PubMed Web of Science ®Google Scholar
• Phua, L.C., et al., 2014. Global fecal microRNA profiling in the identification of biomarkers for colorectal cancer screening among Asians. Oncology reports, 32 (1), 97–104.
   PubMed Web of Science ®Google Scholar
• Qiu, S., et al., 2019. Exploratory analysis of plasma neurotensin as a novel biomarker for early detection of colorectal polyp and cancer. Hormones and cancer, 10 (2–3), 128–135.
   PubMed Web of Science ®Google Scholar
• Ransohoff, D.F., 2021. Evaluating a new cancer screening blood test: unintended consequences and the need for clarity in policy making. JNCI: journal of the national cancer institute, 113 (2), 109–111.
   PubMedGoogle Scholar
• Rawla, P., Sunkara, T., and Barsouk, A., 2019. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Gastroenterology review/przegląd gastroenterologiczny, 14 (2), 89–103.
   PubMed Web of Science ®Google Scholar
• Recio-Boiles, A., and Cagir, B., 2021. ‘Colon cancer’. In StatPearls [Internet]. St. Petersburg, FL: StatPearls Publishing.
   Google Scholar
• Rock, C.L., et al., 2020. American Cancer Society guideline for diet and physical activity for cancer prevention. CA: a cancer journal for clinicians, 70 (4), 245–271.
   PubMed Web of Science ®Google Scholar
• Sabry, D., et al., 2019. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway. Molecular and cellular biochemistry, 454 (1–2), 177–189.
   PubMed Web of Science ®Google Scholar
• Saraiva, M.R., Rosa, I., and Claro, I., 2023. Early-onset colorectal cancer: a review of current knowledge. World journal of gastroenterology, 29 (8), 1289–1303.
   PubMed Web of Science ®Google Scholar
• Sarhadi, V.K., and Armengol, G., 2022. Molecular biomarkers in cancer. Biomolecules, 12 (8), 1021.
   PubMed Web of Science ®Google Scholar
• Sattar, R.S.A., et al., 2022. Diagnostic and prognostic biomarkers in colorectal cancer and the potential role of exosomes in drug delivery. Cellular signalling, 99, 110413.
   PubMedGoogle Scholar
• Sawicki, T., et al., 2021. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers, 13 (9), 2025.
   PubMed Web of Science ®Google Scholar
• Shaker, O.G., Senousy, M.A., and Elbaz, E.M., 2017. Association of rs6983267 at 8q24, HULC rs7763881 polymorphisms and serum lncRNAs CCAT2 and HULC with colorectal cancer in Egyptian patients. Scientific reports, 7 (1), 1–11.
   PubMedGoogle Scholar
• Shapiro, J.A., et al., 2017. A comparison of fecal immunochemical and high-sensitivity guaiac tests for colorectal cancer screening. American journal of gastroenterology, 112 (11), 1728–1735.
   PubMed Web of Science ®Google Scholar
• Sharma, R., 2020. An examination of colorectal cancer burden by socioeconomic status: evidence from GLOBOCAN 2018. EPMA journal, 11 (1), 95–117.
   PubMed Web of Science ®Google Scholar
• Shimura, T., et al., 2019. Urinary cysteine-rich protein 61 and trefoil factor 3 as diagnostic biomarkers for colorectal cancer. Translational oncology, 12 (3), 539–544.
   PubMed Web of Science ®Google Scholar
• Shum, B., Larkin, J., and Turajlic, S., 2022. ‘Predictive biomarkers for response to immune checkpoint inhibition’. In Seminars in cancer biology. Amsterdam, The Netherlands: Elsevier, 4–17.
   Google Scholar
• Siegel, R.L., et al., 2022. Cancer statistics, 2022. CA: a cancer journal for clinicians, 72 (6), 524–541.
   PubMed Web of Science ®Google Scholar
• Simpson, K.L., et al., 2013. A caspase-3 ‘death-switch’ in colorectal cancer cells for induced and synchronous tumor apoptosis in vitro and in vivo facilitates the development of minimally invasive cell death biomarkers. Cell death & disease, 4 (5), e613–e613.
   PubMedGoogle Scholar
• Spaander, M.C.W., et al., 2023. Young-onset colorectal cancer. Nature reviews disease primers, 9 (1), 21.
   PubMed Web of Science ®Google Scholar
• Sveen, A., Kopetz, S., and Lothe, R.A., 2020. Biomarker-guided therapy for colorectal cancer: strength in complexity. Nature reviews clinical oncology, 17 (1), 11–32.
   PubMed Web of Science ®Google Scholar
• Tivey, A., et al., 2022. Circulating tumour DNA—looking beyond the blood. Nature reviews clinical oncology, 19 (9), 600–612.
   PubMed Web of Science ®Google Scholar
• Toden, S., and Goel, A., 2022. Non-coding RNAs as liquid biopsy biomarkers in cancer. British journal of cancer, 126 (3), 351–360.
   PubMed Web of Science ®Google Scholar
• Tsoneva, D.K., et al., 2023. Circulating histones to detect and monitor the progression of cancer. International journal of molecular sciences, 24 (2), 942.
   PubMed Web of Science ®Google Scholar
• Ueno, H., et al., 2019. Prospective multicenter study on the prognostic and predictive impact of tumor budding in stage II colon cancer: results from the SACURA trial. Journal of clinical oncology, 37 (22), 1886–1894.
   PubMed Web of Science ®Google Scholar
• Vekic, B., et al., 2020. A correlation study of the colorectal cancer statistics and economic indicators in selected Balkan countries. Frontiers in public health, 8, 29.
   PubMed Web of Science ®Google Scholar
• Wang, W., et al., 2021. Mortality and years of life lost of colorectal cancer in China, 2005-2020: findings from the national mortality surveillance system. Chinese medical journal, 134 (16), 1933–1940.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2021. FDA-approved and emerging next generation predictive biomarkers for immune checkpoint inhibitors in cancer patients. Frontiers in oncology, 11, 683419.
   PubMed Web of Science ®Google Scholar
• Wender, R.C., et al., 2019. A blueprint for cancer screening and early detection: advancing screening’s contribution to cancer control. CA: a cancer journal for clinicians, 69 (1), 50–79.
   PubMed Web of Science ®Google Scholar
• Wijnands, A.M., et al., 2021. Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: current practice and future perspectives. European journal of internal medicine, 93, 35–41.
   PubMed Web of Science ®Google Scholar
• Xi, Y., and Xu, P., 2021. Global colorectal cancer burden in 2020 and projections to 2040. Translational oncology, 14 (10), 101174.
   PubMed Web of Science ®Google Scholar
• Xie, J., et al., 2021. Elevated N6-methyladenosine RNA levels in peripheral blood immune cells: a novel predictive biomarker and therapeutic target for colorectal cancer. Frontiers in immunology, 12, 760747.
   PubMed Web of Science ®Google Scholar
• Xu, W., et al., 2015. Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer. Discovery medicine, 20 (110), 239–253.
   PubMed Web of Science ®Google Scholar
• Yadav, S., et al., 2017. Gold-loaded nanoporous iron oxide nanocubes: a novel dispersible capture agent for tumor-associated autoantibody analysis in serum. Nanoscale, 9 (25), 8805–8814.
   PubMed Web of Science ®Google Scholar
• Yin, H., et al., 2022. 5-Methylcytosine (m5C) modification in peripheral blood immune cells is a novel non-invasive biomarker for colorectal cancer diagnosis. Frontiers in immunology, 13, 967921.
   PubMed Web of Science ®Google Scholar
• Yuan, D., et al., 2015. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer. Cancer biology & therapy, 16 (2), 268–275.
   PubMed Web of Science ®Google Scholar
• Zhang, H., 2014. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer. World journal of gastroenterology, 20 (20), 6329.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., et al., 2021. Sensitive detection of colorectal cancer in peripheral blood by a novel methylation assay. Clinical epigenetics, 13 (1), 90.
   PubMed Web of Science ®Google Scholar
• Zhao, G., et al., 2020. A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2. Clinica chimica acta, 503, 84–89.
   PubMed Web of Science ®Google Scholar
• Zhao, P., et al., 2019. Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy. Journal of hematology & oncology, 12 (1), 1–14.
   PubMedGoogle Scholar
• Zhou, J., et al., 2021. Colorectal cancer burden and trends: comparison between China and major burden countries in the world. Chinese journal of cancer research, 33 (1), 1–10.
   PubMed Web of Science ®Google Scholar